clinical_trials
Bulevirtide Linked to Less Decompensation in Chronic Hep D With Cirrhosis
Confidence86·multiple reportsImportance88NP-EVT-20261109-FB044BD
(MedPage Today) -- In patients with chronic hepatitis delta (CHD) with cirrhosis, treatment with bulevirtide (Hepcludex) was associated with lower risk of liver decompensation, according to results from a European retrospective study. Among more...
Read the original at the primary source
Bulevirtide Linked to Less Decompensation in Chronic Hep D With Cirrhosis
11/9/2026, 5:54:02 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —